Shanghai Pharmaceuticals Holding Co., Ltd SHPMY
$7.24
-$0.15-1.97%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 689.60M | 814.99M | 793.17M | 780.98M | 840.20M |
| Total Depreciation and Amortization | 406.28M | 394.45M | 394.45M | 344.98M | 362.78M |
| Total Amortization of Deferred Charges | 44.35M | 35.40M | 35.40M | 15.93M | 28.34M |
| Total Other Non-Cash Items | 405.90M | 229.90M | 94.74M | 208.82M | 71.41M |
| Change in Net Operating Assets | -162.56M | -452.40M | -452.40M | -598.82M | -424.16M |
| Cash from Operations | 1.38B | 1.02B | 865.35M | 751.89M | 878.57M |
| Capital Expenditure | -320.25M | -322.77M | -323.73M | -301.68M | -295.31M |
| Sale of Property, Plant, and Equipment | 30.22M | 28.25M | 14.62M | 22.96M | 24.04M |
| Cash Acquisitions | 48.91M | -35.19M | -37.75M | -89.62M | -86.91M |
| Divestitures | 3.66M | 3.80M | 5.60M | 1.61M | 2.33M |
| Other Investing Activities | -91.36M | -139.95M | -216.87M | 266.93M | -40.82M |
| Cash from Investing | -328.82M | -465.86M | -558.13M | -99.80M | -396.67M |
| Total Debt Issued | 65.88B | 69.53B | 69.39B | 75.64B | 74.13B |
| Total Debt Repaid | -72.74B | -74.73B | -71.23B | -73.97B | -71.51B |
| Issuance of Common Stock | 0.00 | 0.00 | 7.38M | 75.26M | 89.83M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -416.15M | -431.90M | -390.22M | -397.18M | -488.69M |
| Other Financing Activities | -560.73M | -1.10B | -1.02B | -1.44B | -1.07B |
| Cash from Financing | -1.46B | -1.31B | -804.98M | -363.95M | -268.75M |
| Foreign Exchange rate Adjustments | 201.90K | -2.23M | -407.70K | 1.90M | -479.80K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -405.81M | -759.95M | -498.17M | 290.04M | 212.67M |